Skip to main content

Table 2 SMARCAs transcription levels between pancreatic cancer and normal tissues (ONCOMINE)

From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer

  Types of pancreatic cancer versus normal pancreatic tissue Fold change P value t test References
SMARCA2 Pancreatic ductal adenocarcinoma − 6.555 0.009 3.107 Buchholz Pancreas [13]
SMARCA3 Pancreatic ductal adenocarcinoma 2.522 0.008 3.688 Buchholz Pancreas [13]
SMARCA4 Pancreatic adenocarcinoma 2.257 7.16E−4 4.459 Logsdon Pancreas [14]
HELLS Pancreatic ductal adenocarcinoma 2.596 0.005 2.867 Grutzmann Pancreas [15]
  Pancreatic carcinoma 2.386 3.50E−8 6.352 Pei Pancreas [16]
  1. Order by Over-expression: Fold Change; P value < 0.01; Fold Change > 2; Gene Rank: Top 10%